Currently Viewing:
Currently Reading
What We're Reading: Bad Drug Ads; DC's Public Hospital; Slowing Parkinson Disease Progression
December 13, 2017 – AJMC Staff
Review Finds Several Biologics Effective in Treating Form of Palmoplantar Psoriasis
December 12, 2017 – Samantha DiGrande
Researchers Say Medicare Advantage Plans Need Better Incentives to Meet Future Demand
December 12, 2017 – Allison Inserro
University, Genetics Firm Find Link Between ADHD, Delay Discounting
December 12, 2017 – Allison Inserro
Welltok Identifies Who's at Risk for Getting and Spreading the Flu
December 12, 2017 – Jaime Rosenberg
What We're Reading: Medical Device Approval; Medical Laboratories Sue Government; ACA Sign-Up Deadline
December 12, 2017 – AJMC Staff
What's the Magic Payment Mix for Medicare Primary Care Providers?
December 11, 2017 – Allison Inserro
Racial Disparities Prevalent in Survival of Patients With Ovarian, Colon, and Breast Cancer
December 11, 2017 – Jaime Rosenberg
Sanofi's Insulin Lispro Follow-On, Admelog, Wins FDA Approval
December 11, 2017 – Mary Caffrey

What We're Reading: Virginia Makes Naloxone Widely Available for Opioid Overdoses

AJMC Staff
What we're reading, November 22, 2016: Virginia declares opioid addiction a public health emergency; House calls for a pause of ongoing Obamacare lawsuit; and Anthem-Cigna antitrust trial begins.
After declaring opioid addiction a public health emergency, Virginia’s health commissioner has made the drug naloxone, used to treat overdoses, widely available. According to The Washington Post, 3 people every day die in Virginia from an overdose and emergency room visits for heroin overdoses are up 89% year over year. Now, the state has issued a blanket prescription for all residents in Virginia to have access to naloxone, and the state’s pharmacies should keep an adequate supply of the drug.

A lawsuit challenging the Affordable Care Act (ACA)’s subsidy program is currently in the Federal Court of Appeals for the DC Circuit, but the House of Representatives is asking the court to pause the lawsuit. The move would allow the new administration to have time to decide how to repeal the ACA and unwind the exchanges, reported POLITICO. Without the Department of Justice (DOJ) to defend the health law, the lower court’s ruling against the ACA would stand, eliminating the subsidies and immediately destabilizing the exchange market.

The antitrust trial for the Anthem-Cigna merger kicked off on Monday with the DOJ and Anthem presenting opening statements that provided different perspectives of the impact of the proposed merger. The DOJ is arguing that the merger would reduce competition, while Anthem’s lawyer argued that the merger would increase the scale of operation and allow Anthem to offer better rates, according to The Wall Street Journal. Joseph Swedish, Anthem’s CEO took to the stand yesterday, and is expected to continue testifying today.

Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!